Literature DB >> 2861619

Cerebrospinal fluid homovanillic acid and hypokinetic side effects of neuroleptics.

M B Bowers.   

Abstract

Eleven psychotic patients treated with neuroleptics for 1 month showed a relatively poor response, more side effects, and a no-tolerance pattern with respect to cerebrospinal fluid (CSF) homovanillic acid (HVA). Within this group the severity of neuroleptic catatonia and Parkinsonian side effects was positively associated with an increase in CSF HVA turnover during the treatment period.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2861619     DOI: 10.1007/bf00428411

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Catatonic reactions to high-potency neuroleptic drugs.

Authors:  A J Gelenberg; M R Mandel
Journal:  Arch Gen Psychiatry       Date:  1977-08

2.  Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity.

Authors:  B S Bunney; A A Grace
Journal:  Life Sci       Date:  1978-10-23       Impact factor: 5.037

Review 3.  Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

Authors:  O Hornykiewicz
Journal:  Br Med Bull       Date:  1973-05       Impact factor: 4.291

4.  Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.

Authors:  T N Chase; J A Schnur; E K Gordon
Journal:  Neuropharmacology       Date:  1970-05       Impact factor: 5.250

5.  Family history and CSF homovanillic acid pattern during neuroleptic treatment.

Authors:  M B Bowers
Journal:  Am J Psychiatry       Date:  1984-02       Impact factor: 18.112

6.  Catatonic stupor and neuroleptic drugs.

Authors:  D R Weinberger; R J Wyatt
Journal:  JAMA       Date:  1978-05-05       Impact factor: 56.272

7.  Modulation by GABA of cholinergic transmission in the striatum.

Authors:  B Scatton; G Bartholini
Journal:  Brain Res       Date:  1980-02-03       Impact factor: 3.252

8.  Importance of dopamine metabolism for clinical effects and side effects of neuroleptics.

Authors:  H M Van Praag; J Korf
Journal:  Am J Psychiatry       Date:  1976-10       Impact factor: 18.112

9.  Intravenous lorazepam in neuroleptic-induced catatonia.

Authors:  G L Fricchione; N H Cassem; D Hooberman; D Hobson
Journal:  J Clin Psychopharmacol       Date:  1983-12       Impact factor: 3.153

Review 10.  Receptors for the age of anxiety: pharmacology of the benzodiazepines.

Authors:  J F Tallman; S M Paul; P Skolnick; D W Gallager
Journal:  Science       Date:  1980-01-18       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.